Johanna Friedl-Naderer
Chief Commercial Officer · 1 filing · Latest: May 13, 2026
Dyne Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | May 13, 2026 | Sale | $18.36 | 228 | $4.2K | 154,353 |